Sandesh Mahatme Vor Biopharma Inc. (VOR) insider trading activity

VOR Quotes by TradingView

Sandesh Mahatme is CFO of Vor Biopharma Inc.. Currently has a direct ownership of 0 shares of VOR, which is worth approximately $0. The most recent transaction as insider was on Dec 05, 2025, when has been sold 694,137 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

Sandesh Mahatme Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 05 2025
SELL
Sale (or disposition) back to the issuer
-
694,137 Reduced 100.0%
0 Common Stock
Jul 09 2025
BUY
Grant, award, or other acquisition
-
13,882,750 Added 50.0%
13,882,750 Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
Director
SM

Sandesh Mahatme

CFO
Austin, TX

Track Institutional and Insider Activities on VOR

Follow Vor Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VOR shares.

Notify only if

Insider Trading

Get notified when an Vor Biopharma Inc. insider buys or sells VOR shares.

Notify only if

News

Receive news related to Vor Biopharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VOR